The Patent Finder

Genedia Biotech Co., Ltd.

Also on record
Records under this name other than patents Genedia Biotech Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Genedia Biotech Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,127,320MIR-193A-3P and Associated Genes Predict Tumorigenesis and Chemotherapy Outcomes
Lapsed on the fee record
Ended Sep 8, 2023 · High confidence
Lapsed on the fee recordEnded Sep 8, 2023High confidence
US 10,238,688Combination Therapies for Bladder Cancer
Lapsed on the fee record
Ended Mar 26, 2023 · High confidence
Lapsed on the fee recordEnded Mar 26, 2023High confidence
US 10,161,008MIR-193A-3P and Associated Genes Predict Tumorigenesis and Chemotherapy Outcomes
Lapsed on the fee record
Ended Dec 25, 2022 · High confidence
Lapsed on the fee recordEnded Dec 25, 2022High confidence
US 10,011,877Treatment of Bladder Cancer to Overcome Chemoresistance
Lapsed on the fee record
Ended Jul 3, 2022 · High confidence
Lapsed on the fee recordEnded Jul 3, 2022High confidence
US 9,540,698MIR-193A-3P and Associated Genes Predict Tumorigenesis and Chemotherapy Outcomes
Lapsed on the fee record
Ended Jan 10, 2021 · High confidence
Lapsed on the fee recordEnded Jan 10, 2021High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited